SCHEMBL4439225

SCHEMBL4439225

OCC1OC(CO)C(O)C1O

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LGALS1 P09382 2/20 0.59
▸ LGALS3 P17931 2/20 0.59
▸ LGALS9 O00182 1/20 0.59
▸ LGALS8 O00214 1/20 0.59
▸ ALDH1A1 P00352 2/20 0.48
▸ TSHR P16473 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ CA12 O43570 3/20 0.45
▸ CA1 P00915 3/20 0.45
▸ CA2 P00918 3/20 0.45
▸ CA9 Q16790 3/20 0.45
▸ GBA1 P04062 1/20 0.44
▸ PYGB P11216 6/20 0.43
▸ GAA P10253 1/20 0.43
▸ OGA O60502 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15314105 1.00 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8ALDH1A1
SCHEMBL19317500 1.00 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8ALDH1A1
SCHEMBL5452516 1.00 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8ALDH1A1
SCHEMBL24115372 1.00 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8ALDH1A1
SCHEMBL13632537 1.00 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8ALDH1A1
SCHEMBL24243426 1.00 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8ALDH1A1
SCHEMBL17931796 1.00 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8ALDH1A1
SCHEMBL13197776 1.00 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8ALDH1A1
SCHEMBL5452134 1.00 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8ALDH1A1
SCHEMBL5444372 1.00 LGALS1 (0.59) LGALS1LGALS3LGALS9LGALS8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0214879-B1 PROCESS FOR SULFATING GLYCOSAMINOGLYCANES, GLYCOSAMINOGLYCANES OBTAINED AND THEIR BIOLOGICAL APPLICATIONS SANOFI (FR) 1990-11-22 — — EP claimed
EP-0214879-A2 Process for sulfating glycosaminoglycanes, glycosaminoglycanes obtained and their biological applications SANOFI (FR) 1987-03-18 — — EP claimed
EP-4296325-B1 COATING COMPOSITION, FOR METAL, WITH IMPROVED OIL RESISTANCE AND ADHESIVENESS AND A PREPARATION METHOD THEREFOR, AND A METAL ARTICLE COATED WITH COMPOSITION SAMYANG CORP (KR) 2026-05-13 — — EP disclosed
US-12616961-B1 Method of producing hydrogen gas IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) 2026-05-05 — — US disclosed
US-20260109875-A1 MULTI-PART WATER-BORNE COATING COMPOSITION AXALTA COATING SYSTEMS IP CO., LLC (US) 2026-04-23 — — US disclosed
EP-4714994-A1 TWO-COMPONENT COMPOSITION PROVIDING FIRE RETARDENCY Henkel AG & Co. KGaA (DE) 2026-03-25 — — EP disclosed
EP-4685179-A1 POLYCARBONATE RESIN COMPOSITION HAVING EXCELLENT IONIZING RADIATION RESISTANCE, AND MOLDED ARTICLE INCLUDING SAME Samyang Corporation (KR) 2026-01-28 — — EP disclosed
US-12509348-B1 Method of producing hydrogen gas from sodium borohydride IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) 2025-12-30 — — US disclosed
US-12503547-B2 Polyol composition using glucose-containing saccharide composition, and polyurethane foam including same SAMYANG CORPORATION (KR) 2025-12-23 — — US disclosed
US-12486169-B1 CaB2O4/PbO/CuO/Pb3O4/PbB2O4/Pb4O(BO3)2 nanocomposite material and method of making IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) 2025-12-02 — — US disclosed
WO-2025242379-A1 BONDED STRUCTURE COMPRISING AN ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM HENKEL AG & CO. KGAA (DE) 2025-11-27 — — WO disclosed
WO-2006036760-A2 MODIFIED PHENOLIC NOVOLAK RESINS AND APPLICATIONS THEREOF INDSPEC CHEMICAL CORPORATION (US) 2006-04-06 — — WO disclosed
US-20060069191-A1 Modified phenolic novolak resins and applications thereof INDSPEC CHEMICAL CORPORATION (US) 2006-03-30 — — US disclosed
EP-0946634-B1 USE OF POLYALCOHOLS AS POLYMER STABILISERS AKCROS CHEM (GB) 2001-11-14 — — EP disclosed
US-6313203-B1 Use of polyalcohols as polymer stabilizers AKCROS CHEMICALS (GB) 2001-11-06 — — US disclosed
US-6013812-A CYCLODEHYDRATING POLYOL IN THE PRESENCE OF WATER AND ACIDIC CATALYST AND ACID-STABLE HYDROGENATING CATALYST IN HYDROGEN ATMOSPHERE DEGUSSA AKTIENGESELLSCHAFT (DE) 2000-01-11 — — US disclosed
US-5013724-A Conversion to amine salt soluble in aprotic solvent SANOFI SOCIETE ANONYME (FR) 1991-05-07 — — US disclosed
EP-0214879-B1 PROCESS FOR SULFATING GLYCOSAMINOGLYCANES, GLYCOSAMINOGLYCANES OBTAINED AND THEIR BIOLOGICAL APPLICATIONS SANOFI (FR) 1990-11-22 — — EP disclosed
EP-0313538-A2 Monoclonal antibody, a process for its preparation and the use thereof CARMEDA AB (SE) 1989-04-26 — — EP disclosed
EP-0214879-A2 Process for sulfating glycosaminoglycanes, glycosaminoglycanes obtained and their biological applications SANOFI (FR) 1987-03-18 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260109875-A1 MULTI-PART WATER-BORNE COATING COMPOSITION EGLN1, ALG1, GLO1 LGALS1 616/4885LGALS3 889/4885LGALS9 458/4885
US-12509348-B1 Method of producing hydrogen gas from sodium borohydride SCNN1G, MPO, SCNN1B LGALS1 163/4885LGALS3 131/4885LGALS9 145/4885
US-12616961-B1 Method of producing hydrogen gas PYM1, SCO2, HAO2 LGALS1 245/4885LGALS3 22/4885LGALS9 230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback